| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/13/2008 | WO2008001115A3 Pharmaceutical combinations of 1-cyclopropyl-3- [3- (5-m0rphoolin-4-ylmethyl-1h-benzoimidazol-2-yl) -lh-1-pyrazol- 4-yl] -urea |
| 03/13/2008 | WO2007147590A3 Solution and method to reduce, treat and/or prevent oxidative stress and cell activation |
| 03/13/2008 | WO2007126363A3 Antisecretory protein for use in the treatment of compartment syndrome |
| 03/13/2008 | WO2007125310A3 Pharmaceutical combinations of pk inhibitors and other active agents |
| 03/13/2008 | US20080064859 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| 03/13/2008 | US20080064854 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 03/13/2008 | US20080064758 Method of treatment or prophylaxis of depression |
| 03/13/2008 | US20080064751 Utilizing lipoxin analogs; polyisoprenyl phosphate signaling inhibition |
| 03/13/2008 | US20080064749 Lipoxin Analogs as Novel Inhibitors of Angiogenesis |
| 03/13/2008 | US20080064746 Lipoxins and Aspirin-Triggered Lipoxins and Their Stable Analogs in the Treatment of Asthma and Inflammatory Airway Diseases |
| 03/13/2008 | US20080064743 Dry powder compound formulations and uses thereof |
| 03/13/2008 | US20080064741 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/13/2008 | US20080064735 Method for controlling harmful organisms in crops of useful plants |
| 03/13/2008 | US20080064731 Remedy for chronic disease |
| 03/13/2008 | US20080064726 Dipeptidyl peptidase-IV (DPP-IV) inhibitor; diabetes mellitus, insulin-resistant diseases, obesity, hypoglycemia ; 2-[4-({2-[(2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoethyl}amino)-4-methylpiperdin-1-yl]-2-oxoethyl acetate monofumarate |
| 03/13/2008 | US20080064722 Agent for promoting interferon-y production |
| 03/13/2008 | US20080064718 Inhibitors of protein tyrosine kinase activity |
| 03/13/2008 | US20080064713 Dry Syrup Containing Loratadine |
| 03/13/2008 | US20080064710 Novel Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases |
| 03/13/2008 | US20080064704 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors |
| 03/13/2008 | US20080064685 Pyrrolo[2,1-C][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 03/13/2008 | US20080064679 Water Soluble Cannabinoids |
| 03/13/2008 | US20080064666 Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| 03/13/2008 | US20080064657 For birds and mammals by oral administration; probiotics; non-competitive inhibitors of alpha -glucosidase; fermenting sucrose in the presence of maltose |
| 03/13/2008 | US20080064651 A 21-base antisense oligonucleotide which inhibits gene expression of testosterone-repressed prostate message-2 by tumor cells; prostate and renal cell cancer; enhanced chemosensitivity, hormone and radiation sensitivities |
| 03/13/2008 | US20080064645 A carbohydrate linked to a fluorophore through a 2-amido-2-(1-hydroxyalkyl)ethoxy linkage; inhibition of caveolar endocytosis, plasma membrane microdomain formation, virus binding and infection, transmembrane signaling, and integrin function in cells; anticarcinogenic and antiinflammatory agents |
| 03/13/2008 | US20080064644 Serum-Free Cell Culture Medium for Mammalian Cells |
| 03/13/2008 | US20080064643 Peptidomimetic antagonists prevent signalling interference of the TLR/IL-R1 receptor system; antiinflammatory agents; autoimmune diseases; cardiovascular and atherogenic diseases; sepsis and shock; transplant rejection |
| 03/13/2008 | US20080064638 Proteins related to schizophrenia and uses thereof |
| 03/13/2008 | US20080064637 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/13/2008 | US20080064635 Whey protein concentrate containing docosahexaenoic acid, arachidonic acid and other fatty acids |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080064630 Prolonged circulation time; combined with such as human growth hormone or fragments; nucleic acid constructs, vectors, host cells; culturing and harvesting |
| 03/13/2008 | US20080064082 Control of function of intracellular Ca ion |
| 03/13/2008 | US20080063898 Materials containing multiple layers of vesicles |
| 03/13/2008 | US20080063732 Tetanus toxin, conotoxin, curare, botulinum toxin, aluminum chloride, glycopyrrolate, robinol; treat facial rhytides, hyperhidrosis, muscle, sweat gland hyperactivity condition; collagen, hydrogel, dextran, hyaluronic acid, epinephrine diffusion-limiting agent, anti-metabolic agent |
| 03/13/2008 | US20080063721 Sustained release microparticle; a biodegradable and biocompatible polymer; active agent risperidone, 9-hydroxy-risperidone; pharmaceutically acceptable acid addition salts; inhibiting serotonergic or dopaminergic overstimulation |
| 03/13/2008 | US20080063717 Anti-NCR antibody or immunoreactive fragments and an interleukin, cytokine; administered together or separately; tablet, powder, pastes, patches, granules, microgranules, nanoparticules, colloid solution, aqueous solution, injectable solutions, sprays, or liposomes; subcutaneous injection |
| 03/13/2008 | US20080063706 Methods and Medicaments for Administration of Ibuprofen |
| 03/13/2008 | US20080063701 Lipids of a liposome comprising cationic N1-cholesteryloxycarbonyl-3,7-diazanononane-1,9-diamine and/or noncationic dioleoyl phosphatidylethanolamine and short interference RNA (siRNA) are coupled, reversibly or irreversibly, to one or more polymers; drug delivery; freeze drying |
| 03/13/2008 | US20080063698 Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use |
| 03/13/2008 | US20080063667 ProDer P 1 Expressed in a Prokaryotic Cell |
| 03/13/2008 | US20080063656 Adenoviral Vector Compositions |
| 03/13/2008 | US20080063655 nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein; host cell; new locus comprising four genes has now surprisingly been found; swine dysentery |
| 03/13/2008 | US20080063654 Prostate Cancer Vaccine |
| 03/13/2008 | US20080063652 co-culture of hematopoietic progenitor cells and lymphoreticular stromal cells in a porous solid scaffold, resulting in unexpectedly high numbers of regulatory T cells |
| 03/13/2008 | US20080063650 membrane-bound complement regulatory protein; use in enhancing the activity of antiproliferative/beta-glucan immunotherapy; mCRP antagonist; a therapeutic ligand capable of activating complement; and beta-glucan |
| 03/13/2008 | US20080063649 pretreatment step involving a highly specific and high affinity neutralizing antibody |
| 03/13/2008 | US20080063648 immunization against proliferative enteritis, known as ileitis |
| 03/13/2008 | US20080063643 HLA-binding motif in its sequence; recognized by an HLA-A2- or HLA-A24-restricted cytotoxic T cell; nucleotide; antibody; vector; diagnosid and prognosis of hepatitis C virus infection |
| 03/13/2008 | US20080063638 Mitotic kinesin-like protein-1, MKLP1, and uses therof priority |
| 03/13/2008 | US20080063631 prophylaxis of vascular system disorders in mammals by administering apoptotic cells and/or bodies derived from leukocytes or lymphocytes |
| 03/13/2008 | US20080063630 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy |
| 03/13/2008 | US20080063626 Minimization of drug oxidation in drug irradiated excipients formulations |
| 03/13/2008 | US20080063621 surface treated lipids encapsulating drugs, dyes, genetic engineered DNA or biological molecule of interest into liposomes or micelles, used for drug delivery, facilitating controlled release and/or tissue targeting |
| 03/13/2008 | US20080063620 biodegradable amphiphillic copolymers comprising hydrophobic and hydrophillic segments, capable of undergoing transitions that results in an increase in viscosity in response to a change in temperature, used for drug delivery, prevention of surgical adhesions, as bioadhesives and in tissue engineering |
| 03/13/2008 | US20080063600 use of deactivated lymphocytes, antibodies, drug mixtures and adjuvants, for the treatment or prevention of Cruetzfield-Jacobs disease in humans or animals; immunology; bioassays |
| 03/13/2008 | US20080060645 Dry Powder Inhalant Composition |
| 03/13/2008 | DE112004002217T5 Proteinbildungskomplex mit einem c-Jun-Protein, Nucleinsäure, codierend denselben und Verfahren unter Verwendung desselben The same protein complex formation with a c-Jun protein, nucleic acid encoding the same and methods using |
| 03/13/2008 | CA2663042A1 Serum albumin binding proteins with long half-lives |
| 03/13/2008 | CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators |
| 03/13/2008 | CA2661992A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/13/2008 | CA2661878A1 Anti-activin a antibodies and uses thereof |
| 03/12/2008 | EP1897889A2 Method of modulating the profileration of medullary thyroid carcinoma cells |
| 03/12/2008 | EP1897881A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1897880A1 1,3-benzothiazinone derivative and use thereof |
| 03/12/2008 | EP1897876A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1897872A1 Activator for peroxisome proliferator-activated receptor |
| 03/12/2008 | EP1897871A1 Benzenoid ansamycin derivative |
| 03/12/2008 | EP1897561A1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 03/12/2008 | EP1897558A1 Solid preparation |
| 03/12/2008 | EP1897553A1 Inhibitor of stem cell proliferation and uses thereof |
| 03/12/2008 | EP1897546A1 Combined compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 03/12/2008 | EP1897540A2 Inhibition of STAT3 signal transduction for human cancer therapy |
| 03/12/2008 | EP1897539A1 Anti-fatigue composition |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896077A2 Methods and compositions for the prevention and treatement of inflammatory disease |
| 03/12/2008 | EP1896004A1 Compositions ameliorating a reduced diurnal activity and/or depressive symptoms |
| 03/12/2008 | EP1539693B1 Cannabinoid receptor agonists |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | EP1495009B1 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 03/12/2008 | EP1450775B1 C-kit inhibitors for treating bacterial infections |
| 03/12/2008 | EP1450751B1 Nanoparticle delivery vehicle |
| 03/12/2008 | EP1416935B1 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives |
| 03/12/2008 | EP1414809B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/12/2008 | EP1404675B1 Dpp-iv-inhibiting purine derivatives for the treatment of diabetes |
| 03/12/2008 | EP1225184B1 Human antithrombin variants |
| 03/12/2008 | EP1220680B1 Echinacea supplement and method of manufacture |
| 03/12/2008 | EP1178803B1 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 03/12/2008 | EP0876487B1 Mammalian cx3c chemokine genes |
| 03/12/2008 | EP0833659B1 Therapeutic fragments of von willebrand factor |
| 03/12/2008 | EP0614374B2 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 03/12/2008 | CN101141972A Gastrointestinal drug composition |
| 03/12/2008 | CN101141960A Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione |
| 03/12/2008 | CN101139343A Synthesis of piperidine and piperazine compounds as ccr5 antagonists |
| 03/12/2008 | CN101138593A Preparation method of Chinese medicine unction and emplastrum for treating external hemorrhoid (ancient ink ointment for curing piles ) |
| 03/12/2008 | CN101138576A Codonopsis pilosula fermentation liquor and uses thereof |
| 03/12/2008 | CN101138547A Carthamus tinctorius yellow colour injection and method of preparing the same |
| 03/12/2008 | CN100374568C TAO protein kinases and methods of use thereof |
| 03/12/2008 | CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |